about
Functions and mechanisms of action of CCN matricellular proteinsEts-1 is essential for connective tissue growth factor (CTGF/CCN2) induction by TGF-β1 in osteoblasts.An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules.A soluble factor from Trypanosoma cruzi inhibits transforming growth factor-ß-induced MAP kinase activation and gene expression in dermal fibroblasts.CXCL12 induces connective tissue growth factor expression in human lung fibroblasts through the Rac1/ERK, JNK, and AP-1 pathways.Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.Association of E26 Transformation Specific Sequence 1 Variants with Rheumatoid Arthritis in Chinese Han PopulationIncreased fibroblast functionality on CNN2-loaded titania nanotubesThe Overexpression of TGF-β and CCN2 in Intrauterine Adhesions Involves the NF-κB Signaling Pathway.Induction of Connective Tissue Growth Factor Expression by Hypoxia in Human Lung Fibroblasts via the MEKK1/MEK1/ERK1/GLI-1/GLI-2 and AP-1 Pathways.Ets-1 upregulation mediates angiotensin II-related cardiac fibrosis.Scar wars: is TGFbeta the phantom menace in scleroderma?Molecular requirements for induction of CTGF expression by TGF-beta1 in primary osteoblasts.Regulation of CCN2 mRNA expression and promoter activity in activated hepatic stellate cells.Connective tissue growth factor hammerhead ribozyme attenuates human hepatic stellate cell functionA large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype.Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease?Molecular regulation of CCN2 in the intervertebral disc: lessons learned from other connective tissuesCCN2: a novel, specific and valid target for anti-fibrotic drug intervention.Molecular basis of organ fibrosis: potential therapeutic approaches.ALK5 inhibition blocks TGFβ-induced CCN1 expression in human foreskin fibroblasts.Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.Thrombin-induced CCN2 expression in human lung fibroblasts requires the c-Src/JAK2/STAT3 pathway.CCN2 expression and localization in melanoma cells.Loss of PPARγ expression by fibroblasts enhances dermal wound closure.ALK5 inhibition blocks TGFß-induced CCN2 expression in gingival fibroblasts.Analysis of CCN2 promoter activity in PANC-1 cells: regulation by ras/MEK/ERKEureka! Ets a target for fibrosis!Toll-like receptor 4 activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with IPF.MEK/ERK inhibitors: proof-of-concept studies in lung fibrosis.Rho-ROCK signaling differentially regulates chondrocyte spreading on fibronectin and bone sialoprotein.Getting out of a sticky situation: targeting the myofibroblast in sclerodermaCeramide inhibits CCN2 expression in fibroblastsCCN2 YAPs at cancer.Connective tissue growth factor is induced in bleomycin-induced skin scleroderma.Mithramycin reduces expression of fibro-proliferative mRNAs in human gingival fibroblasts.Ethanol-mediated expression of connective tissue growth factor (CCN2) in mouse pancreatic stellate cells.The association between miR-499a polymorphism and oral squamous cell carcinoma progression.MEKK1, JNK, and SMAD3 mediate CXCL12-stimulated connective tissue growth factor expression in human lung fibroblasts.Unique mechanisms of connective tissue growth factor regulation in airway smooth muscle in asthma: Relationship with airway remodelling.
P2860
Q24642303-6992CCD6-D73F-42D5-BB51-B91D5B717EA8Q31059602-C910D486-8632-4D20-999C-25478ED72566Q33483669-3013C9C1-7C73-4D72-AE1A-1C676BFB7662Q34023102-515F003B-40C9-44A8-B42D-BCB4360AF09DQ34046726-1098D771-1A71-439E-875C-F71D8C2F9A59Q34721223-B95BF2C6-83B0-45C3-87FD-13F7FD3E10BCQ35737609-FD105ACE-5022-4C42-BD52-9E3C7E194621Q35797553-837220BB-E1EE-4419-946E-64A48375E3AFQ35882412-E1A7E7FD-C88C-4CA1-9BDA-675899DE751CQ36093588-93820550-1F5B-4E53-A0B6-A5875D73F070Q36261328-D7F6CBDA-C4AC-46C6-86EC-A77CF37979F2Q36506934-8661F373-F41C-448D-AED1-90A5CE6E6CE0Q36724904-3CE8C27B-F7FD-4EC7-AD1C-29BAEC445BA4Q36942777-8E12A3C0-2FB4-4EE3-9F8A-D8B4BA28A053Q37304264-706E1C46-804B-4A47-A788-D9E4213E463FQ37346330-8AA470F8-A332-404F-AE56-75C86C568628Q37373460-5CA3EC71-D211-4583-9CB9-27AB7956C8A4Q38097283-EF17A849-0C72-4B52-AB1A-57C0FDD3431BQ38121157-BC4168BA-ECC6-45AD-8A6D-C860E277EEAAQ38121751-DFD4A704-C0F4-4A8B-B818-2F36EBA3A040Q38586349-3CDBF296-D420-4C4C-87BB-CE0823FE7B64Q38649653-A58ACD0C-38FD-4E2F-BADA-0AA1CB635C98Q39252052-6319EE37-26CB-43D4-A826-9E57B1962F65Q39525723-86C208A1-A071-44CF-A71B-DA29BDBE7706Q39629362-B43CD6B4-B2FB-4349-B5D7-E0663BC91B50Q39830423-B1C99EB9-1944-4F3D-BBCE-9C22BE532B4BQ39982168-56A40B50-1F31-4798-9FBF-1ADEA20D493EQ39986867-352BBAD0-7AC1-4DB0-9920-43EDEBABE817Q40463304-3134DC30-7EB7-482E-9DB4-5B38B4D3DFA9Q40816517-1216537D-552B-4D7D-A57E-7442F8FF7F25Q41330497-DC83CCAB-BA05-49B6-B9A7-4F03A2FE4666Q41816319-8CCCEE29-408D-4135-9947-6ED117242700Q41822219-43B3D7CF-9B3C-47C0-8880-DDC4DEE3F6F7Q42154999-B5E0BD1B-D41F-4416-B1BF-B56BADB4494EQ42917225-B6373A3A-9786-472E-91CD-EDDDC473D79BQ45353079-7E7A3CCA-6C5F-4983-B608-19592359F9F0Q46091334-5B2DE770-30CF-4B34-A6D8-7D308C8DCE21Q48321790-BAD176CC-4850-44F4-A449-DD2566E7CA02Q51418425-3C1C20B1-279A-4EA3-A694-2F9C54D17233Q52727962-B32690D5-3AA0-41AD-BF29-4EBC4B4577FF
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The induction of CCN2 by TGFbeta1 involves Ets-1.
@en
type
label
The induction of CCN2 by TGFbeta1 involves Ets-1.
@en
prefLabel
The induction of CCN2 by TGFbeta1 involves Ets-1.
@en
P2093
P2860
P356
P1476
The induction of CCN2 by TGFbeta1 involves Ets-1.
@en
P2093
Andrew Leask
Jason S Rockel
Jonathan P Van Beek
Laura Kennedy
Suzanne M Bernier
P2860
P2888
P356
10.1186/AR1890
P577
2006-01-16T00:00:00Z